| Term 
 
        | What type of drugs can be used to treat Essential hypertension? |  | Definition 
 
        | Diuretics ACE inhibitors Angiotensin II receptor blockers (ARBs) Calcium Channel blockers |  | 
        |  | 
        
        | Term 
 
        | What type of drugs can be used to treat CHF? |  | Definition 
 
        | Diuretics ACE inhibitors/ARBs β-Blockers (compenstated CHF) K+-sparing diuretics |  | 
        |  | 
        
        | Term 
 
        | What drugs are contraindicated in cardiogenic shock? |  | Definition 
 
        | β-Blockers 
 can be used in compensated CHF, and used cautiously in decompensated CHF |  | 
        |  | 
        
        | Term 
 
        | What type of drugs can be used to treat hypertension in Diabetic patients? |  | Definition 
 
        | ACE inhibitors/ARBs Calcium channel Blockers Diuretics β-blockers α-blockers |  | 
        |  | 
        
        | Term 
 
        | What type of drugs are protective against diabetic nephropathy? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | ↑ cGMP → smooth muscle relaxation   Vasodilates arterioles > veins   afterload reduction |  | 
        |  | 
        
        | Term 
 
        | Clinical Uses of Hydralazine |  | Definition 
 
        | Severe Hypertension, CHF   First-line therapy for hypertension in Pregnancy, with methyldopa 
 
 
 
 |  | 
        |  | 
        
        | Term 
 
        | What is frequently administered with Hydralazine to prevent reflex tachycardia? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What drug is contraindicated in angina and coronary artery disease? Why? |  | Definition 
 
        | Hydralazine   Toxicity: Compensatory tachycardia fluid retention nausea headache angina Lupus-like syndrome |  | 
        |  | 
        
        | Term 
 
        | What are the Calcium Channel Blockers? |  | Definition 
 
        | Nifedipine Verapamil Diltiazem Amlodipine |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Calcium Channels Blockers (Nifedipine, Verpamil, Diltiazem, Amlodipine) |  | Definition 
 
        | Block voltage-dependent L-type calcium channels of cardiac and smooth muscle → ↓ muscle contractility   Vascular smooth muscle → nifedipine>diltiazem>verapamil   Heart → verapamil>diltiazem>nifedipine   |  | 
        |  | 
        
        | Term 
 
        | What CCBs work best in the vascular smooth muscle? |  | Definition 
 
        | Nifedipine > Diltiazem > Verapamil |  | 
        |  | 
        
        | Term 
 
        | What CCBs work best in the Heart? |  | Definition 
 
        | Verapamil > Diltiazem > Nifedipine   (Verapamil = Ventricle) |  | 
        |  | 
        
        | Term 
 
        | Clinical Uses of Calcium Channel Blockers   (Nifedipine, Verapamil, Diltiazem, Amlodipine) |  | Definition 
 
        | Hypertension Angina Arrhythmias (not nifedipine) Prinzmetal's angina Raynaud's |  | 
        |  | 
        
        | Term 
 
        | What CCB should not be used in the treatment of Arrhythmias? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Toxicity of Calcium Channel Blockers   (Nifedipine, Verapamil, Diltiazem, Amlodipine) |  | Definition 
 
        | Cardiac Depression AV Block Peripheral Edema Flushing  Dizziness Constipation |  | 
        |  | 
        
        | Term 
 
        | What 3 drugs are used for the treatment Malignant Hypertension? |  | Definition 
 
        | Nitroprusside (↑cGMP)   Fenoldopam (Dopamine D1 receptor agonist)   Diazoxide (K+ channel opener) |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Nitroprusside   (Malignant hypertension treatment) |  | Definition 
 
        | Short Acting   ↑cGMP via direct release of NO   (can cause cyanide toxicity, releases CN) |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Fenoldopam   (Malignant Hypertension Treatment) |  | Definition 
 
        | Dopamine D1 receptor agonist   Relaxes renal vascular smooth muscle |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Diazoxide   (Malignant Hypertension Treatment) |  | Definition 
 
        | K+ channel opener   Hyperpolarizes and relaxes vascular smooth muscle   Can cause hyperglycemia (reduces insulin release) |  | 
        |  | 
        
        | Term 
 
        | How can Diazoxide cause Hyperglycemia? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mechanism of Nitroglycerin (isosorbide dinitrate) |  | Definition 
 
        | Vasodilate by releasing nitric oxide in smooth muscle →  ↑ cGMP and smooth muscle relaxation   Dilate veins >> arteries   ↓ preload |  | 
        |  | 
        
        | Term 
 
        | Clinical use of Nitroglycerin, isosorbide dinitrate |  | Definition 
 
        | Angina Pulmonary Edema   (aphrodisiac and erection enhancer) |  | 
        |  | 
        
        | Term 
 
        | Toxicity of Nitroglycerin, isosorbide dinitrate |  | Definition 
 
        | Reflex tachycardia Hypotension Flushing Headache "Monday Disease" in industrial exposure   |  | 
        |  | 
        
        | Term 
 
        | What is "Monday disease"? What causes this? |  | Definition 
 
        | Development of tolerance for vasodilating action during the work week and loss of tolerance over the weekend Resulting in → Tachycardia, Dizziness, and headache on reexposure   Caused by Nitroglycerin, isosorbide dinitrate |  | 
        |  | 
        
        | Term 
 
        | What is the Goal of Antianginal Therapy? How is this accomplished? |  | Definition 
 
        | Goal:  Reduction of myocardial O2 consumption (MVO2)   Decreasing 1 or More of MVO2 Determinants: End-diastolic volume Blood Pressure Heart Rate Contractility Ejection Time |  | 
        |  | 
        
        | Term 
 
        | How do Nitrates affect preload? |  | Definition 
 
        | ↓ End-Diastolic Volume ↓ Blood Pressure ↑ Contractility (reflex response) ↑ Heart Rate (reflex response) ↓ Ejection Time ↓ MVO2 |  | 
        |  | 
        
        | Term 
 
        | How Do β-Blockers affect afterload? |  | Definition 
 
        | ↑ End-diastolic volume ↓ Blood Pressure ↓ Contractility ↓ Heart Rate ↑ Ejection Time ↓ MVO2   |  | 
        |  | 
        
        | Term 
 
        | How do Nitrates and β-Blockers work together in the treatment of angina? |  | Definition 
 
        | No Effect or ↓ End-diastolic volume ↓ Blood Pressure Little/No effect Contractility ↓ Heart Rate Little/No effect Ejection Time ↓↓ MVO2 |  | 
        |  | 
        
        | Term 
 
        | What CCB have a similar effect to Nitrates in antianginal thearpy?   What CCB has a similar effect to β-blockers in antianginal therapy? |  | Definition 
 
        | Nifedipine ~ Nitrates   Verapamil ~ β-Blockers |  | 
        |  | 
        
        | Term 
 
        | What β-blockers are contraindicated in angina? |  | Definition 
 
        | Pindolol and Acebutolol 
 Partial β-agonists |  | 
        |  | 
        
        | Term 
 
        | What are the HMG-CoA reductase inhibitors? |  | Definition 
 
        | Lovastatin Pravastatin Simvastatin Atorvastatin Rosuvastatin |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Action 
 HMG-CoA reductase Inhibitors Lovastatin Pravastatin Simvastatin Atorvastatin Rosuvastatin |  | Definition 
 
        | Inhibit Cholesterol Precursor, Mevalonate |  | 
        |  | 
        
        | Term 
 
        | Side Effects/Problems 
   HMG-CoA reductase inhibitors  Lovastatin Pravastatin Simvastatin Atorvastatin Rosuvastatin |  | Definition 
 
        | Hepatotoxicity (↑ LFTs) Rhabdomyolysis |  | 
        |  | 
        
        | Term 
 
        | Effects on Cholesterol 
 HMG-CoA reductase inhibitors    Lovastatin Pravastatin Simvastatin Atorvastatin Rosuvastatin |  | Definition 
 
        | LDL - ↓↓↓ HDL - ↑ Triglycerides - ↓ |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Action 
 Niacin |  | Definition 
 
        | Inhibits lipolysis in adipose tissue Reduces Hepatic VLDL secretion into circulation |  | 
        |  | 
        
        | Term 
 
        | Side Effects/Problems 
 Niacin |  | Definition 
 
        | Red, Flushed Face (↓ by aspirin or long-term use)   Hyperglycemia (acanthosis nigricans)   Hyperuricemia (exacerbates gout) |  | 
        |  | 
        
        | Term 
 
        | Effects on Cholesterol 
 Niacin |  | Definition 
 
        | LDL - ↓↓ HDL - ↑↑ Triglycerides - ↓ |  | 
        |  | 
        
        | Term 
 
        | What are the Bile Acid Sequestrant Drugs? |  | Definition 
 
        | Cholestyramine Colestipol Colesevelam |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Action 
   Bile Acid Sequestrants Cholestyramine Colestipol Colesevelam |  | Definition 
 
        | Prevent intestinal reabsorption of bile acids →  Liver must use cholesterol to make more |  | 
        |  | 
        
        | Term 
 
        | Side Effects/Problems 
   Bile Acid Sequestrants Cholestyramine Coletipol Colesevelam |  | Definition 
 
        | Patients hate it → Tastes bad and causes GI discomfort ↓ absorption of fat-soluble vitamins Cholesterol Gallstones |  | 
        |  | 
        
        | Term 
 
        | Effects on Cholesterol 
   Bile Acid Sequestrants Cholestyramine Colestipol Colesevelam |  | Definition 
 
        | LDL - ↓↓ HDL - slight ↑ Triglicerides- slight ↑ |  | 
        |  | 
        
        | Term 
 
        | What is the cholesterol absorption blocking drug? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mechanism of Action 
   Cholesterol Absorption Blocker Ezetimibe |  | Definition 
 
        | Prevent cholesterol reabsorption at small intestine brush border   (Binds NPC1L1 protein on GI epithelial cells and hypatocytes) |  | 
        |  | 
        
        | Term 
 
        | Effects on Cholesterol 
   Cholesterol absorption Blockers Ezetimibe |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Gemfibrozil Clofibrate Bezafibrate Fenofibrate |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Action 
   Fibrates Gemifibrozil Clofibrate Bezafibrate Fenofibrate |  | Definition 
 
        | Upregulate LPL → ↑ TG clearance |  | 
        |  | 
        
        | Term 
 
        | Side Effects/Problems 
   Fibrates Gemifibrozil Clofibrate Bezafibrate Fenofibrate |  | Definition 
 
        | Myositis Hepatotoxicity ↑ LFTs Cholesterol Gallstones |  | 
        |  | 
        
        | Term 
 
        | Effect on Cholesterol 
 
 Fibrates Gemfibrozil Clofibrate Bezafibrate Fenofibrate |  | Definition 
 
        | LDL - ↓ HDL - ↑ Triglycerides - ↓↓↓ |  | 
        |  | 
        
        | Term 
 
        | What are the Lipid-Lowering Agents? |  | Definition 
 
        | HMG-CoA Reductase Inhibitors  Lovastatin Pravastatin Simvastatin Atorvastatin Rosuvastatin   Niacin   Bile Acid Resins Cholestyramine Colestipol Colesevelam   Cholesterol Absorption Blockers Ezetimibe   Fibrates Gemfibrozil Clofibrate Bezafibrate Fenofibrate                       |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Action 
 Cardiac Glycosides Digoxin |  | Definition 
 
        | Direct inhibition of Na/K ATPase → indirect inhibition of Na/Ca exchanger/antiport   ↑ [Ca] → positive inotropy   Stimulates Vagus Nerve |  | 
        |  | 
        
        | Term 
 
        | Clinical Use 
 Cardiac Glycosides Digoxin |  | Definition 
 
        | CHF - ↑ contractility Atrial Fibrillation - ↓ conduction at AV node and depression of SA node |  | 
        |  | 
        
        | Term 
 
        | Toxicity 
 Cardiac Glycosides Digoxin |  | Definition 
 
        | Cholinergic - nausea, vomiting, diarrhea, blurry yellow vision   ECG - ↑PR, ↓QT, scooping, T-wave inversion, arrhythmia, hyperkalemia   Worsened by → renal failure (↓ excretion) hypokalemia (allows digoxin binding at K-binding site on Na/K ATPase) quinidine (↓ digoxin clearance, displases digoxin from tissue binding sites) |  | 
        |  | 
        
        | Term 
 
        | How is Digoxin Toxicity treated? |  | Definition 
 
        | Slowly normalize K+ Lidocaine Cardiac pacer anti-dig Fab Fragments Mg2+ |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Action 
 Nesiritide |  | Definition 
 
        | Recombinant B-type natriuretic peptide Causes ↑ in cGMP and vasodilation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acute Decompensated Heart Failure 
 (jugular venous distension - most sensitive clinical sign) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Class I Antiarrhythmics 
 Na+ channel Blockers |  | Definition 
 
        | Class IA Quinidine Procainamide Disopyramide   Class IB Lidocaine Mexiletine Tocainide   Class IC Flecainide Propafenone   |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Mechanism of Action   All Class I Na+ Channel Blockers     |  | Definition 
 
        | Local Anesthetics Slow or Block Conduction (Especially in depolarized cells) ↓ slope of phase 0 depolarization ↑ threshold for firing in abnormal pacemaker cells State Dependent (selectively depress tissue that is frequently depolarized)  Hyperkalemia →↑ toxicity for all class I drugs 
 [image] |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Mechanism of Action   Class IA Na Channel Blockers   Quinidine Procainamide Disopyramide |  | Definition 
 
        | ↑ AP duration ↑ effective refractory period ↑ QT interval   Atrial and Ventricular Arrhythmias (especially reentrant and ectopic supraventricular and ventricular tachycardia)   [image] |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Toxicity 
 Class IA 
 Quinidine Procainamide Disopyramide |  | Definition 
 
        | Thrombocytopenia Torsades de Pointes   Quinidine: Cinchonism - headache, tinnitus   Procainamide: reversible SLE-like syndrome   |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Mechanism of Action   Class IB 
 Lidocaine Mexiletine Tocainide |  | Definition 
 
        | ↓ AP duration Preferentially affect ischemic or depolarized Purkinje and ventricular tissue  Useful in: Acute Ventricular Arrhythmias (especially post-MI) Digitalis-induced arrythmias   IB is Best post-MI [image] |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Toxicity   Class IB   Lidocaine Mexiletine Tocainide |  | Definition 
 
        | Local anesthetic CNS stimulation/Depression Cardiovascular depression |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Mechanism of Action   Class IC   Flecainide Propafenone |  | Definition 
 
        | No Effect on AP duration   Useful in: V-Tachs that progress to V-Fib Intractable SVT   Last resort in refractory tachyarrhythmias   For Patients WITHOUT structural abnormalities [image] |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Class II β-Blockers |  | Definition 
 
        | Propranolol Esmolol Metoprolol Atenolol Timolol |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Mechanism of Action   Class II   Propranolol Esmolol Metoprolol Atenolol Timolol |  | Definition 
 
        | ↓ cAMP, ↓ Ca2+ Currents Suppress abnormal pacemakers by ↓ slope of phase 4 AV node particularly sensitive → ↑ PR interval 
 Esmolol - short acting           [image] [image] |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Clinical Uses   Class II   Proranolol Esmolol Metoprolol Atenolol Timolol |  | Definition 
 
        | V-Tach SVT Slowing ventricular rate during atrial fibrillation and atrial flutter |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Toxicity 
 Class II 
 Propranolol Esmolol Metoprolol Atenolol Timolol 
 |  | Definition 
 
        | Impotence Exacerbation of Asthma Cardiovascular effects (Bradycardia, AV block, CHF) CNS effects (sedation, sleep alterations) May mask hypoglycemia signs   Metoprolol: Dyslipidemia |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
   Treatment of β-Blocker overdose   Propranolol Esmolol Metoprolol Atenolol Timolol |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Class III   K+ Channel Blockers |  | Definition 
 
        | Ibutilide Sotalol Bretylium Amiodarone Dofetilide   (K IS BAD) |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Mechanism of Action 
 Class III 
 Ibutilide Sotalol Bretylium Amiodarone Dofetilide |  | Definition 
 
        | ↑ AP duration ↑ Effective Refractory Period ↑ QT interval   Used when other antiarrhythmics fail   [image] |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Toxicity 
 Class III 
 Ibutilide Sotalol Bretylium Amiodarone Dofetilide |  | Definition 
 
        | Ibutilide: Torsades de Pointes   Sotalol: Torsades de Pointes Excessive β-Block   Bretylium: New arrhythmias Hypotension   Amiodarone: Pulmonary fibrosis Hepatotoxicity Hypothyroidism/Hyperthyroidism Corneal Deposits Skin Deposits → photodermatitis neurologic effects constipation cardiovascular effects (bradycardia, heart block, CHF)     |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 What drug has class I, II, II and IV effects? |  | Definition 
 
        | Amiodarone   Remember to check PFTs, LFTs, and TFTs when using Amiodarone |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythnimics 
 Class IV   Ca2+ blockers |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Mechanism of Action 
 Class IV 
 Verapamil Diltiazem |  | Definition 
 
        | ↓ conduction velocity ↑ Effective Refractory Period ↑ PR interval   Used in prevention of nodal arrhythmias   [image] |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Toxicity   Class IV   Verapamil Diltiazem |  | Definition 
 
        | Constipation Flushing Edema CV effects (CHF, AV Block, Sinus Node Depression) |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Mechanism of Action   Adenosine |  | Definition 
 
        | ↑ K+ out of cells → hyperpolarizing the cell + ↓ ICa   Drug of Choice for: Diagnosing/Abolishing Supraventricular Tachycardia   Very Short Acting |  | 
        |  | 
        
        | Term 
 
        | Antiarrhythmics 
 Toxicity 
 Adenosine |  | Definition 
 
        | Flushing Hypotension Chest Pain 
 Blocked by: Theophylline |  | 
        |  | 
        
        | Term 
 
        |   Antihypertensive Therapy 
   Hypertension plus...   CHF |  | Definition 
 
        | Initial Therapy 
 Diuretics ACE inhibitor/ARB β-Blocker Aldoseterone antagonist 
 Avoid 
 β-Blockers → acute decompensated CHF or cardiogenic shock Calcium Channel Blockers |  | 
        |  | 
        
        | Term 
 
        | Antihypertensive 
   Hypertension plus....   DM |  | Definition 
 
        | Initial Therapy 
 ACE inhibitor/ARB Thiazide 
 Avoid 
 β-Blockers |  | 
        |  | 
        
        | Term 
 
        | Antihypertensives 
   Hypertension plus...   Post-MI/CAD |  | Definition 
 
        | Initial Therapy 
 Thiazide β-Blocker ACE inhibitor/ARB CCB (for angina) Nitrates (for angina) |  | 
        |  | 
        
        | Term 
 
        | Antihypertensives 
   Hypertension plus...   Atrial Fibrillation   |  | Definition 
 
        | Initial Therapy 
 Diltiazem/Verapamil (for rate control) |  | 
        |  | 
        
        | Term 
 
        | Antihypertensives 
   Hypertension plus...   Bradycardia   (what to avoid only) |  | Definition 
 
        | Avoid 
   Diltiazem/Verapamil β-Blockers |  | 
        |  | 
        
        | Term 
 
        | Antihypertensives 
   HTN plus...   Renal insufficiency   |  | Definition 
 
        | Initial Therapy 
 ACE inhibitor/ARB (for proteinuria) 
 Avoid 
 ACE/ARB → may increase creatinine K+ sparing diuretics |  | 
        |  | 
        
        | Term 
 
        | Antihypertensives 
   HTN plus...   BPH |  | Definition 
 
        | Initial Therapy 
 α-blocker |  | 
        |  | 
        
        | Term 
 
        | Antihypertensives 
   HTN plus...   Hyperthyroidism |  | Definition 
 
        | Initial Therapy 
   Propranolol |  | 
        |  | 
        
        | Term 
 
        | Antihypertensives 
   HTN plus...   Hyperparathyroidism |  | Definition 
 
        | Initial Treatment 
 Loop Diuretic 
 Avoid 
 Thiazide |  | 
        |  | 
        
        | Term 
 
        | Antihypertensives 
   HTN plus...   Osteoporosis |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antihypertensives 
   HTN plus...   Pregnancy   |  | Definition 
 
        | Initial Therapy 
 Hydralazine Methyldopa Labetalol Dihydropyridine CCB 
 Avoid 
 ACE inhibitors/ARBs |  | 
        |  |